[Federal Register Volume 77, Number 236 (Friday, December 7, 2012)]
[Notices]
[Page 73056]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-29613]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Application for a License To Export High-Enriched Uranium

    Pursuant to 10 CFR 110.70 (b) ``Public Notice of Receipt of an 
Application,'' please take notice that the Nuclear Regulatory 
Commission (NRC) has received the following request for an export 
license. Copies of the request are available electronically through 
ADAMS and can be accessed through the Public Electronic Reading Room 
(PERR) link http://www.nrc.gov/reading-rm.html at the NRC Homepage.
    A request for a hearing or petition for leave to intervene may be 
filed within thirty days after publication of this notice in the 
Federal Register. Any request for hearing or petition for leave to 
intervene shall be served by the requestor or petitioner upon the 
applicant, the office of the General Counsel, U.S. Nuclear Regulatory 
Commission, Washington, DC 20555; the Secretary, U.S. Nuclear 
Regulatory Commission, Washington, DC 20555; and the Executive 
Secretary, U.S. Department of State, Washington, DC 20520.
    A request for a hearing or petition for leave to intervene may be 
filed with the NRC electronically in accordance with NRC's E-Filing 
rule promulgated in August 2007, 72 FR 49139 (Aug. 28, 2007). 
Information about filing electronically is available on the NRC's 
public Web site at http://www.nrc.gov/site-help/e-submittals.html. To 
ensure timely electronic filing, at least 5 (five) days prior to the 
filing deadline, the petitioner/requestor should contact the Office of 
the Secretary by email at HEARINGDOCKET@NRC.GOV, or by calling (301) 
415-1677, to request a digital ID certificate and allow for the 
creation of an electronic docket.
    In addition to a request for hearing or petition for leave to 
intervene, written comments, in accordance with 10 CFR 110.81, should 
be submitted within thirty (30) days after publication of this notice 
in the Federal Register to Office of the Secretary, U.S. Nuclear 
Regulatory Commission, Washington, DC 20555, Attention: Rulemaking and 
Adjudications
    The information concerning this application for an export license 
follows.

                                         NRC Export License Application
                                            [Description of material]
----------------------------------------------------------------------------------------------------------------
  Name of applicant, date of
 application, date  received,     Material type      Total quantity           End use             Destination
  application No., docket No.
----------------------------------------------------------------------------------------------------------------
DOE/NNSA-Y-12 National          High-Enriched      5.8 kilograms      To fabricate targets    Belgium.
 Security Complex.               Uranium (93.2%).   uranium-235        at CERCA AREVA Romans
October 10, 2012..............                      contained in 6.2   in France and to
October 12, 2012..............                      kilograms          irradiate targets at
XSNM3729......................                      uranium.           the BR-2 Research
11006053......................                                         Reactor in Belgium,
                                                                       the HFR Research
                                                                       Reactor in the
                                                                       Netherlands, the
                                                                       OSIRIS Research
                                                                       Reactor in France,
                                                                       and the LVR-15
                                                                       Research Reactor in
                                                                       the Czech Republic
                                                                       for ultimate use for
                                                                       production of medical
                                                                       isotopes at the
                                                                       Institute for
                                                                       Radioelements in
                                                                       Belgium.
----------------------------------------------------------------------------------------------------------------


     Dated this 19th day of November 2012 at Rockville, Maryland.

    For the Nuclear Regulatory Commission.
Mark R. Shaffer,
Deputy Director, Office of International Programs.
[FR Doc. 2012-29613 Filed 12-6-12; 8:45 am]
BILLING CODE 7590-01-P